1
|
Toh Y, Pencil SD and Nicolson GL: A novel
candidate metastasis-associated gene, mta1, differentially
expressed in highly metastatic mammary adenocarcinoma cell lines.
cDNA cloning, expression, and protein analyses. J Biol Chem.
269:22958–22963. 1994. View Article : Google Scholar : PubMed/NCBI
|
2
|
Toh Y, Kuwano H, Mori M, Nicolson GL and
Sugimachi K: Overexpression of metastasis-associated MTA1 mRNA in
invasive oesophageal carcinomas. Br J Cancer. 79:1723–1726. 1999.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Toh Y, Oki E, Oda S, Tokunaga E, Ohno S,
Maehara Y, Nicolson GL and Sugimachi K: Overexpression of the MTA1
gene in gastrointestinal carcinomas: Correlation with invasion and
metastasis. Int J Cancer. 74:459–463. 1997. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhu X, Guo Y, Li X, Ding Y and Chen L:
Metastasis-associated protein 1 nuclear expression is associated
with tumor progression and clinical outcome in patients with
non-small cell lung cancer. J Thorac Oncol. 5:1159–1166. 2010.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Jang KS, Paik SS, Chung H, Oh YH and Kong
G: MTA1 overexpression correlates significantly with tumor grade
and angiogenesis in human breast cancers. Cancer Sci. 97:374–379.
2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Dannenmann C, Shabani N, Friese K, Jeschke
U, Mylonas I and Brüning A: The metastasis-associated gene MTA1 is
upregulated in advanced ovarian cancer, represses ERbeta, and
enhances expression of oncogenic cytokine GRO. Cancer Biol Ther.
7:1460–1467. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Nicolson GL, Nawa A, Toh Y, Taniguchi S,
Nishimori K and Moustafa A: Tumor metastasis-associated human MTA1
gene and its MTA1 protein product: Role in epithelial cancer cell
invasion, proliferation and nuclear regulation. Clin Exp
Metastasis. 20:19–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kai L, Wang J, Ivanovic M, Chung YT,
Laskin WB, Schulze-Hoepfner F, Mirochnik Y, Satcher RL Jr and
Levenson AS: Targeting prostate cancer angiogenesis through
metastasis-associated protein 1 (MTA1). Prostate. 71:268–280. 2011.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Pakala SB, Rayala SK, Wang RA, Ohshiro K,
Mudvari P, Reddy SD, Zheng Y, Pires R, Casimiro S, Pillai MR, et
al: MTA1 promotes STAT3 transcription and pulmonary metastasis in
breast cancer. Cancer Res. 73:3761–3770. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ishikawa M, Osaki M, Yamagishi M, Onuma K,
Ito H, Okada F and Endo H: Correlation of two distinct
metastasis-associated proteins, MTA1 and S100A4, in angiogenesis
for promoting tumor growth. Oncogene. 38:4715–4728. 2019.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Ran FA, Hsu PD, Wright J, Agarwala V,
Scott DA and Zhang F: Genome engineering using the CRISPR-Cas9
system. Nat Protoc. 8:2281–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Welti J, Loges S, Dimmeler S and Carmeliet
P: Recent molecular discoveries in angiogenesis and antiangiogenic
therapies in cancer. J Clin Invest. 123:3190–3200. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Teleanu RI, Chircov C, Grumezescu AM and
Teleanu DM: Tumor Angiogenesis and Anti-Angiogenic Strategies for
Cancer Treatment. J Clin Med. 9:E842019. View Article : Google Scholar
|
15
|
Jászai J and Schmidt MH: Trends and
challenges in tumor anti-angiogenic therapies. Cells. 8:E11022019.
View Article : Google Scholar
|
16
|
Rajabi M and Mousa SA: The role of
angiogenesis in cancer treatment. Biomedicines. 5:E342017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Herbert SP and Stainier DY: Molecular
control of endothelial cell behaviour during blood vessel
morphogenesis. Nat Rev Mol Cell Biol. 12:551–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Apte RS, Chen DS and Ferrara N: VEGF in
signaling and disease: Beyond discovery and development. Cell.
176:1248–1264. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
21
|
Jayson GC, Kerbel R, Ellis LM and Harris
AL: Antiangiogenic therapy in oncology: Current status and future
directions. Lancet. 388:518–529. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ferrara N and Kerbel RS: Angiogenesis as a
therapeutic target. Nature. 438:967–974. 2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Haibe Y, Kreidieh M, El Hajj H, Khalifeh
I, Mukherji D, Temraz S and Shamseddine A: Resistance mechanisms to
anti-angiogenic therapies in cancer. Front Oncol. 10:2212020.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Bergers G and Hanahan D: Modes of
resistance to anti-angiogenic therapy. Nat Rev Cancer. 8:592–603.
2008. View
Article : Google Scholar : PubMed/NCBI
|
25
|
van Beijnum JR, Nowak-Sliwinska P,
Huijbers EJ, Thijssen VL and Griffioen AW: The great escape; the
hallmarks of resistance to antiangiogenic therapy. Pharmacol Rev.
67:441–461. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Pakala SB, Reddy SD, Bui-Nguyen TM,
Rangparia SS, Bommana A and Kumar R: MTA1 coregulator regulates LPS
response via MyD88-dependent signaling. J Biol Chem.
285:32787–32792. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li DQ, Pakala SB, Reddy SD, Peng S,
Balasenthil S, Deng CX, Lee CC, Rea MA and Kumar R:
Metastasis-associated protein 1 is an integral component of the
circadian molecular machinery. Nat Commun. 4:25452013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Mitchell DC and Bryan BA: Anti-angiogenic
therapy: Adapting strategies to overcome resistant tumors. J Cell
Biochem. 111:543–553. 2010. View Article : Google Scholar : PubMed/NCBI
|